Bio-Rad Laboratories

+$32.38 (+4.58%) Today
$0.00 (0.00%) As of 10:58 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BIO and other ETFs, options, and stocks.

About BIO

Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the Life Sciences and Clinical Diagnostics segments.

CEO
Norman D. Schwartz
Employees
8,000
Headquarters
Hercules, California
Founded
1952

BIO Key Statistics

Market Cap
22.07B
Price-Earnings Ratio
5.20
Dividend Yield
—
Average Volume
108.06K
High Today
$756.52
Low Today
$714.00
Open Price
$714.00
Volume
289.51K
52 Week High
$756.52
52 Week Low
$472.84

BIO News

BenzingaJul 29

Recap: Bio-Rad Laboratories Q2 Earnings

Shares of Bio-Rad Laboratories (NYSE:BIO) moved higher by 0.2% in after-market trading after the company reported Q2 results. Quarterly Results Earnings per s
ReutersJul 27

Bio-Rad, 10x Genomics settle genomics patent war

REUTERS/Lim Huey Teng Summary Summary Related documents Settlement ends long-running, multi-front dispute over genetic-analysis tech Parties agree to cross-l

BIO Earnings

$1.15
$2.50
$3.86
$5.21
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
$2.66 per share
Actual
$3.54 per share
Replay Earnings Call
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure